DWP-216262

N/A

Report date: 2025/03/31 16:54:20

Base Information

Drug NameDWP-216262
Drug Alias NameDWP-216262
ClassificationBiologics
Mechanisms of ActionTranscriptional enhancer factor TEF-1 inhibitorsTranscriptional enhancer factor TEF-4 inhibitors
TargetsTranscriptional enhancer factor TEF-1Transcriptional enhancer factor TEF-4
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A